Artal Group as of Dec. 31, 2016
Portfolio Holdings for Artal Group
Artal Group holds 78 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blue Buffalo Pet Prods | 46.7 | $2.1B | 88M | 24.04 | |
| Lexicon Pharmaceuticals (LXRX) | 17.7 | $796M | 58M | 13.83 | |
| Weight Watchers International | 7.5 | $337M | 29M | 11.45 | |
| MetLife (MET) | 2.1 | $94M | 1.8M | 53.89 | |
| Celgene Corporation | 2.1 | $93M | 800k | 115.75 | |
| Incyte Corporation (INCY) | 1.7 | $75M | 750k | 100.27 | |
| Alexion Pharmaceuticals | 1.5 | $67M | 550k | 122.35 | |
| Regeneron Pharmaceuticals (REGN) | 1.5 | $66M | 180k | 367.09 | |
| Agios Pharmaceuticals (AGIO) | 1.2 | $56M | 1.4M | 41.73 | |
| Wells Fargo & Company (WFC) | 1.2 | $55M | 1.0M | 55.11 | |
| JPMorgan Chase & Co. (JPM) | 1.1 | $52M | 600k | 86.29 | |
| Bristol Myers Squibb (BMY) | 1.0 | $47M | 800k | 58.44 | |
| Chipotle Mexican Grill (CMG) | 1.0 | $43M | 115k | 377.32 | |
| Biogen Idec (BIIB) | 0.9 | $43M | 150k | 283.58 | |
| BioMarin Pharmaceutical (BMRN) | 0.9 | $41M | 500k | 82.84 | |
| Bank of America Corporation (BAC) | 0.8 | $35M | 1.6M | 22.10 | |
| iShares FTSE/Xinhua China 25 Index (FXI) | 0.8 | $35M | 1.0M | 34.71 | |
| Wal-Mart Stores (WMT) | 0.8 | $35M | 500k | 69.12 | |
| Bluebird Bio (BLUE) | 0.7 | $32M | 523k | 61.70 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $26M | 700k | 37.44 | |
| Sarepta Therapeutics (SRPT) | 0.5 | $22M | 800k | 27.43 | |
| Alibaba Group Holding (BABA) | 0.5 | $22M | 250k | 87.81 | |
| Athene Holding Ltd Cl A | 0.4 | $19M | 400k | 47.99 | |
| Nektar Therapeutics (NKTR) | 0.4 | $18M | 1.5M | 12.27 | |
| International Business Machines (IBM) | 0.4 | $17M | 100k | 165.99 | |
| Pfizer (PFE) | 0.4 | $16M | 500k | 32.48 | |
| Eli Lilly & Co. (LLY) | 0.3 | $15M | 200k | 73.55 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.3 | $15M | 200k | 73.67 | |
| Zto Express Cayman (ZTO) | 0.3 | $12M | 1.0M | 12.07 | |
| Amicus Therapeutics (FOLD) | 0.3 | $12M | 2.4M | 4.97 | |
| Kite Pharma | 0.2 | $11M | 250k | 44.84 | |
| Array BioPharma | 0.2 | $11M | 1.3M | 8.79 | |
| Agenus (AGEN) | 0.2 | $10M | 2.5M | 4.12 | |
| Neurocrine Biosciences (NBIX) | 0.2 | $9.7M | 250k | 38.70 | |
| Ionis Pharmaceuticals (IONS) | 0.2 | $9.6M | 200k | 47.83 | |
| Beigene (BGNE) | 0.2 | $9.1M | 300k | 30.36 | |
| Ironwood Pharmaceuticals (IRWD) | 0.2 | $7.9M | 517k | 15.29 | |
| Horizon Pharma | 0.2 | $8.1M | 500k | 16.18 | |
| Sage Therapeutics (SAGE) | 0.2 | $7.7M | 150k | 51.06 | |
| Atara Biotherapeutics (ATRA) | 0.2 | $7.1M | 500k | 14.20 | |
| Avexis | 0.2 | $7.2M | 150k | 47.73 | |
| Seres Therapeutics (MCRB) | 0.1 | $6.9M | 700k | 9.90 | |
| Morgan Stanley (MS) | 0.1 | $6.3M | 150k | 42.25 | |
| Jd (JD) | 0.1 | $6.4M | 250k | 25.44 | |
| Juno Therapeutics | 0.1 | $5.7M | 300k | 18.85 | |
| BioTime | 0.1 | $4.6M | 1.3M | 3.61 | |
| Ignyta | 0.1 | $4.5M | 850k | 5.30 | |
| Elf Beauty (ELF) | 0.1 | $4.3M | 150k | 28.94 | |
| Chemocentryx | 0.1 | $4.0M | 546k | 7.40 | |
| Macrogenics (MGNX) | 0.1 | $4.1M | 200k | 20.44 | |
| Acceleron Pharma | 0.1 | $3.8M | 150k | 25.52 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $3.5M | 50k | 70.32 | |
| Radius Health | 0.1 | $3.8M | 100k | 38.03 | |
| Axovant Sciences | 0.1 | $3.7M | 300k | 12.42 | |
| Global Blood Therapeutics In | 0.1 | $3.6M | 246k | 14.45 | |
| Loxo Oncology | 0.1 | $3.2M | 100k | 32.12 | |
| Minerva Neurosciences | 0.1 | $3.0M | 251k | 11.75 | |
| Regenxbio Inc equity us cm (RGNX) | 0.1 | $3.0M | 160k | 18.55 | |
| Intellia Therapeutics (NTLA) | 0.1 | $3.3M | 250k | 13.11 | |
| Ac Immune Sa (ACIU) | 0.1 | $3.2M | 250k | 12.98 | |
| Spark Therapeutics | 0.1 | $2.5M | 50k | 49.90 | |
| Cellectis S A (CLLS) | 0.1 | $2.5M | 150k | 16.95 | |
| Celldex Therapeutics | 0.1 | $2.4M | 675k | 3.54 | |
| Clovis Oncology | 0.1 | $2.2M | 50k | 44.42 | |
| Chimerix (CMRX) | 0.1 | $2.3M | 500k | 4.60 | |
| Noveliontherapeuti.. | 0.1 | $2.2M | 256k | 8.42 | |
| Medicines Company | 0.0 | $1.7M | 50k | 33.94 | |
| Zafgen | 0.0 | $1.6M | 500k | 3.18 | |
| Aimmune Therapeutics | 0.0 | $1.7M | 82k | 20.45 | |
| Aduro Biotech | 0.0 | $1.1M | 100k | 11.40 | |
| Adaptimmune Therapeutics (ADAP) | 0.0 | $1.2M | 300k | 4.05 | |
| Nantkwest | 0.0 | $1.3M | 225k | 5.72 | |
| Achaogen | 0.0 | $781k | 60k | 13.02 | |
| Dimension Therapeutics | 0.0 | $1.0M | 235k | 4.35 | |
| Novavax | 0.0 | $630k | 500k | 1.26 | |
| Cempra | 0.0 | $560k | 200k | 2.80 | |
| Oncocyte | 0.0 | $452k | 64k | 7.05 | |
| Colucid Pharmaceuticals | 0.0 | $203k | 5.6k | 36.41 |
